We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -1.03 | -1.06% | 96.47 | 97.47 | 96.85 | 97.21 | 1,426,045 | 22:29:19 |
From May 2019 to May 2024
By Jessica Sier
Novartis AG said Thursday that it will offer medicines on a zero-profit basis to financially-strained countries to assist in the treatment of Covid-19 symptoms.
The Swiss pharmaceuticals company said the initiative will include 15 medicines that help treat gastro-intestinal illness, acute respiratory symptoms, pneumonia and septic shock for low-income and lower-middle-income patients.
Novartis said the medicines will be made available to governments, non-governmental organizations and other institutional customers in up to 79 countries.
Write to Jessica Sier at jessica.sier@wsj.com
(END) Dow Jones Newswires
July 16, 2020 01:41 ET (05:41 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
